Pacific Bio (PACB) Tops Q1 EPS by 2c

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.23), $0.02 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $19.1 million versus the consensus estimate of $18.02 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• AeroVironment (AVAV) Tops Q4 EPS by 36c
• Evercore ISI Upgrades Owens Corning (OC) to Outperform